Evidence map›Paper›PMID 40011839›Full record

SynthesisBMC pediatrics2025

Efficacy of prebiotic, probiotic and synbiotic administration in improving growth in children aged 0-59 months living in low- and middle-income countries: a systematic review and meta-analysis.

Marietou Khouma, Mamadou Diallo, Doudou Sow, Aicha Djigal, Ndeye Sokhna Diop, Stephen Allen, Babacar Faye

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Probiotic biogeography and sepsis prevention in the neonatal intestine.bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marietou KhoumaDepartment of Animal Biology, Faculty of Science and Technology, Cheikh Anta Diop University of Dakar, Dakar, Senegal. marietou.khouma@ucad.edu.sn.ORCID 0009-0002-5825-4743
Mamadou Diallo *Department of Animal Biology, Faculty of Science and Technology, Cheikh Anta Diop University of Dakar, Dakar, Senegal.
Doudou Sow *Faculty Parasitology-Mycologie, UFR Sciences de La Santé, Gaston Berger University of Saint Louis, Saint Louis, Senegal.
Aicha Djigal *Department of Animal Biology, Faculty of Science and Technology, Cheikh Anta Diop University of Dakar, Dakar, Senegal.
Ndeye Sokhna Diop *Faculty of Medecine, Pharmacy and Odontology, Cheikh Anta Diop University of Dakar, Dakar, Senegal.
Stephen Allen *Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Babacar Faye *Faculty of Medecine, Pharmacy and Odontology, Cheikh Anta Diop University of Dakar, Dakar, Senegal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoor growth is one of the major obstacles to human development, affecting millions of children under the age of 5 years, particularly those living in low- and middle-income countries (LMICs). The objective of this review was to evaluate the efficacy of administering pre-, pro- or synbiotics on the growth of children aged 0-59 months living in LMICs.

methodsGoogle scholar, Pubmed, clinical trial.org and Science Direct databases were searched in April 2023 for randomised controlled trials of pre-, pro- or synbiotics that evaluated growth in under fives in LMICs. The primary outcome were weight and height gain. Secondary outcomes were head circumference, body mass index gain and Z score. Random-effects meta-analysis was used to calculate mean differences for continuous outcomes. Grading of Recommendations Assessment, Development and Evaluation criteria was used to assess certainty of the evidence.

resultsEight trials involving 1375 children under 5 years of age were identified. Meta-analysis of 6 RCTs (n = 991 children) revealed a significant difference in favor of the experimental group (n = 579) compared the control group (n = 412) for weight gain: (MD = 0.33 kg, 95% CI 0.11 to 0.55); low-certainty evidence. Sub-group analysis revealed that pre-, pro, or synbiotics may be more effective in malnourished that healthy children (p = 0.003). Meta-analysis of height gain for 4 RCTs (n = 845) found that there was no significant difference between the experimental group (n = 496) and the control group (n = 349) (MD = 0.31 cm; 95% CI -0.36 to 0.98); low-certainty evidence. In sub-group analysis, prebiotics had a greater impact on height gain than synbiotics (p = 0.03). In the only study reporting an increase in head circumference (n = 32 children), this was not improved by the administration of synbiotics. However, administration of synbiotics to undernourished children significantly improved BMI gain.

conclusionThe evidence for the administration of pre-, pro- or synbiotics on the growth of children in LMICs is weak. Administration of pre-, pro- or synbiotics may improve weight gain in both healthy and malnourished children. Prebiotics and synbiotics had a significant effect on weight gain. Further research is needed due to the small number of studies, short duration of administration and small sample size.

Indexed as

Child DevelopmentPrebioticsProbioticsSynbioticsBody HeightChild, PreschoolDeveloping CountriesHumansInfantInfant, NewbornRandomized Controlled Trials as TopicWeight GainPrebioticsChildrenGrowthLMICPrebioticsProbioticsSynbiotics

Identifiers

PMID40011839
PMCPMC11866818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.